Merseburger A S, Anastasiadis A G, Hennenlotter J, Schilling D, Simon P, Machtens S A, Serth J, Stenzl A, Kuczyk M A
Department of Urology, Eberhard Karls University, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany.
World J Urol. 2006 Nov;24(5):579-84. doi: 10.1007/s00345-006-0103-1. Epub 2006 Aug 9.
Tissue microarrays (TMAs) are used to simultaneously study the expression of proteins in hundreds of tissue samples, offering the important advantage to screen large tissue banks for biomarker expression and to simultaneously examine serial sections obtained from the same tumor specimen by a time- and cost-effective analytical approach. This review article presents an overview of the importance and the impact of this technique in cancer research with increasing number of investigations using TMAs in its eighth anniversary. Its application, limitations, and selected previous study results regarding urologic malignancies are presented and discussed.
组织微阵列(TMAs)用于同时研究数百个组织样本中蛋白质的表达,具有重要优势,可在大型组织库中筛选生物标志物表达,并通过一种经济高效的分析方法同时检查从同一肿瘤标本获取的连续切片。在其诞生八周年之际,随着越来越多的研究使用TMAs,这篇综述文章概述了该技术在癌症研究中的重要性和影响。文中介绍并讨论了其在泌尿生殖系统恶性肿瘤方面的应用、局限性以及此前一些选定的研究结果。